(a) The department shall continuously collect de‑identified information regarding the medical cannabis registry and dispensary programs established pursuant to chapters 329 and 329D, including but not limited to information regarding the:
(1) Quantities of cannabis cultivated and dispensed;
(2) Number of qualifying patients;
(3) Geographic areas in which cannabis is cultivated and consumed;
(4) Prices of cannabis and related products;
(5) Number of employment opportunities related to cannabis; and
(6) Economic impact of cannabis cultivation and sales.
(b) The department of health and dispensaries licensed pursuant to chapter 329D shall provide de-identified aggregated data as required by the department pursuant to this section.
(c) Upon request, the department shall provide an analysis of the aggregated de-identified data to the department of health and the legislature.